Legro RS. Detection of insulin resistance and its treatment in adolescents with polycystic ovary syndrome. J Pediatr Endocrinol Metab 2002;15(Suppl 5):1367–1378.
87.
ACOG Practice Bulletin No. 109. Cervical cytology screening. Obstet Gynecol 2009;114:1409–1420.
88.
Church DG, Vancil JM, Vasanawala SS. Magnetic resonance imaging for uterine and vaginal anomalies. Curr Opin Obstet Gynecol 2009;21:379–389.
89.
Economy KE, Barnewolt C, Laufer MR. A comparison of MRI and laparoscopy in detecting pelvic structures in cases of vaginal agenesis. J Pediatr Adolesc Gynecol 2002;15:101–104.
90.
Warren-Ulanch J, Arslanian S. Treatment of PCOS in adolescence. Best Pract Res Clin Endocrinol Metab 2006;20:311–330.
91.
Demers C, Derzko C, David M, et al. Gynaecological and obstetric management of women with inherited bleeding disorders. Int J Gynaecol Obstet 2006;95:75–87.
92.
Parker MA, Sneddon AE, Arbon P. The menstrual disorder of teenagers (MDOT) study: determining typical menstrual patterns and menstrual disturbance in a large population-based study of Australian teenagers. BJOG 2010;117:185–192.
93.
Lethaby A, Augood C, Duckitt K, et al. Nonsteroidal anti-inﬂammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev 2007;4:CD000400.
93a. U.S. Food and Drug Adminstration. FDA approves lysteda to treat heavy menstrual bleeding. http://www.fda.gov/About FDA/Stay
Informed/RSSFeeds/ucm144575.htm 94.
Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 2006;38:90–96.
95.
Anonymous. Facts on American teens’ sexual and reproductive health. New York: Guttmacher Institute, 2010.
96.
Anonymous. How is the 3 in 10 statistic calculated? Fact Sheet, The National Campaign to Prevent Teen Pregnancy. Pregnancy. Wash ington, DC: 2008. Available at http://www.thenationalcampaign.org/ resources/pdf/FastFacts 3in10.pdf 97.
Lethaby A, Irvine G, Cameron I. Cyclical progestogens for heavy menstrual bleeding. Cochrane Database Syst Rev 2008;1: CD001016.
98.
Speroff L, Fritz MA. Dysfunctional uterine bleeding. In Clinical gynecologic endocrinology and infertility. New York: Lippincott Williams & Wilkins, 2005:558–559.
99.
Fraser IS, Porte RJ, Kouides PA, et al. A benefit-risk review of systemic haemostatic agents: part 2: in excessive or heavy menstrual bleeding. Drug Saf 2008;31:275–282.
100.